The present invention relates to the use of native hepoxilins and of hepoxilin analogs for the regulation of insulin secretion and to the use of hepoxilin analogs as anti-inflammatory, anti-diabetic and anti-thrombotic compounds.

La présente invention concerne l'utilisation des hepoxilins indigènes et des analogues de hepoxilin pour le règlement de la sécrétion d'insuline et à l'utilisation des analogues de hepoxilin en tant que composés anti-inflammatoires, antidiabétiques et antithrombiques.

 
Web www.patentalert.com

< Cocoa extract compounds and methods for making and using the same

< Compositions, kits, methods, and apparatus for transvascular delivery of a composition to an extravascular tissue of a mammal

> Use of lipoxygenase metabolite of arachidonic acid and its derivatives in capsaicin-channel agonist

> Methods of modifying feeding behavior using compounds with afinity for the human hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)

~ 00095